Multiple respiratory viruses are competing to infect our airways this season. Will they suppress COVID-19, or will they coexist in patients? Experts outline two key scenarios with distinct outcomes.
Early predictions suggested SARS-CoV-2—the virus behind the COVID-19 pandemic—might weaken in warmer weather. Yet it persists aggressively. As of August 9, Agence France-Presse (AFP) reported over 19.6 million global cases since late December, with nearly 730,000 deaths.
As autumn and winter approach, a critical question emerges: How will SARS-CoV-2 interact with other respiratory viruses?
The novel coronavirus will circulate through October, Christmas, and beyond. Enhanced testing, quarantines, and treatments for severe cases will be essential. Hospitals face a dual viral challenge this year, compounded by seasonal flu.
Distinguishing infections is a primary hurdle. "Influenza, COVID-19, and other respiratory illnesses present nearly identical symptoms," notes University of Nottingham's Barbara Rath. "Even loss of taste and smell, common in COVID-19, isn't exclusive to it."
Robust diagnostic testing is vital to identify the precise viral culprit. As Debora MacKenzie writes in The Guardian, protocols differ: "COVID-19 demands full PPE, unlike flu where vaccines offer protection."
Understanding SARS-CoV-2's interplay with other viruses from the outset is key.
Colds start in September, followed by respiratory syncytial virus (RSV) in October-November—threatening young children and seniors. Flu peaks through spring, claiming an average of 12,000 lives annually in France.
These waves stem from "viral interference," where dominant viruses suppress rivals. The puzzle: Where does COVID-19 fit in this viral sequence?
Co-infections occur when two viruses strike simultaneously, heightening concerns for the upcoming flu season. Notably, the first COVID death outside China—a 44-year-old Filipino—also had influenza.
Whether flu worsened the outcome is unclear, but the patient's youth raises alarms. "Co-infection outcomes appear poor," cautions Florian Krammer of Mount Sinai School of Medicine.
In Wuhan, early 2020 saw overlapping flu and COVID-19, with many dual infections. Mortality matched COVID-only cases, but patients showed elevated heart damage and inflammation—likely from immune overreaction.
This winter's reality remains uncertain. Optimists anticipate strong viral interference, with early outbreaks potentially curbing COVID-19. Pessimists brace for parallel surges, straining healthcare systems.
